Abstract Cultivation of the marine-derived streptomycete isolate B8005 delivered three known antibiotics, resistomycin (1), resistoflavin (3a) and tetracenomycin (4), and a further member of the rare resistomycin class, the weakly antibiotically active 1-hydroxy-1-norresistomycin (2). From a related marine strain B4842, 1 and resistoflavin methyl ether (3b) have been isolated. The formation of 2 is of interest from a biosynthetic point of view.
carbon sources was tested with SFN2-Biolog plates (Hayward, CA, USA) using BMS-N as basal medium [9] . Growth was obtained with: a -cyclodextrin, dextrin, glycogen, tween 40 turanose, methylpyruvate, mono-methylsuccinate, citric acid, D-glucoronic acid, a-hydroxy butyric acid, b-hydroxy butyric acid, keto butyric acid, a-keto valeric acid, sebacic acid, succinic acid, bromosuccinic acid, glucuronamide, alaninamide, L-alanyl-glycine, L-asparagine, L-aspartic acid, L-glutamic acid, glycyl-L-aspartic acid, glycyl-L-glutamic acid, L-histidine, L-leucine, L-ornithine, L-phenylalanine, proline, L-pyroglutamic acid, serine, L-threonine, g-amino butyric acide, urocanic acide, inosine, uridine, thymidine, 2-aminoethanol, glycerol, glucose-6-phosphate. The strain B4842 from mud sediment of a coastal site of Mauritius (Indian Ocean) was isolated on Olson medium containing 22 g actinomycete isolation agar (Difco) and 5 g glycerol in 1 litre of 50% natural sea water. The strain showed similar properties as B8005. Reference cultures of both strains are held in the Collection of Marine Actinomycetes at the Alfred-Wegener-Institute for Polar and Marine Research in Bremerhaven.
The Streptomyces strain B8005 was fermented on a 15 litre scale. After defatting with cyclohexane, the crude ethyl acetate extract was pre-separated on a medium pressure silica gel column with a chloroform/methanol gradient into four fractions. Further purification of the fractions on Sephadex LH-20 delivered a new antibiotic, 1-hydroxy-1-norresistomycin [10] (2). In addition, three known quinones, resistomycin (1), resistoflavin (3a) and tetracenomycin D (4) were obtained as yellow (1, 3a) and red (4) solids, respectively, which showed colour reactions with dilute sodium hydroxide characteristic of peri-hydroxy quinones. In a similar manner, a 20 litre batch fermentation of S. sp. B4842 delivered after usual work-up 44 mg of 1 and 2.4 mg of 3b. The known compounds were identified by a search in AntiBase [11] using the molecular weight and the 1 H NMR data, and by comparison with reference 531 (1). The only major shift difference was displayed between the aliphatic quaternary carbon at d 46.0 (C-1) in 1 and the aliphatic hydroxylated carbon atom at d 74.1 (C-1) in 2.
The detailed evaluation of the 1 H, 13 C and the HMBC data (see arrows in formula 2) in comparison with the molecular formulae of 1 and of the new resistomycin derivative showed the latter to be the new 1-hydroxy-1-nor derivative 2, where one of the aliphatic methyl group at C-1 in 1 was replaced by an OH group. As a consequence, 2 is optically active, where 1 is not. Resistomycin (1) is a decaketide, where the geminal C-1 methyl groups are introduced as C1 units by means of adenosyl-methionine [12] . It seems plausible that the biosyntheses of 1 and 2 differ in this final step.
In addition to 1, compound 3b was obtained from extracts of S. sp. B4842 as a yellow solid with the molecular formula C 23 H 18 O 7 , as inferred from EI-HRMS, m/z 406.1051. Its IR spectrum showed a broadened hydroxyl absorption at 3400, and signals at 1660, 1640 and 1600 cm Ϫ1 which indicated the presence of two or more conjugated carbonyls. In addition to three chelated OH groups and three 1 H singlets of aromatic protons, the 1 H NMR spectrum showed a methoxyl signal at d 3.40, an aromatic methyl, and geminal methyl groups at d 1.56. These data were comparable with the resistoflavin methyl ether 3b, which was further confirmed by a 13 C NMR signal at d 58.0. Indeed, an identical product was obtained, when 3a was refluxed in methanol in the presence of ptoluene sulfonic acid. When we re-cultivated the strain B4842 and strictly avoided methanol during work-up, 3b was not detectable by TLC or HPLC diode array screening; resistoflavin (3a) was isolated instead. It cannot be excluded therefore that 3b was generated as an artifact during the isolation procedure.
Resistomycin (1) [1, 2] , resistoflavin (3a) [2, 3] and tetracenomycin D (4) [4] showed antibacterial and antitumor activity [13, 14] as reported in the literature. Compounds 1 and 3a were mentioned to have also antiviral [15] and antiprotozoan activity [3] . The new 1-hydroxy-1-norresistomycin (2) showed antibacterial activity against Escherichia coli, Staphylococcus aureus and Streptomyces viridochromogenes (Tü 57), the activity (MIC Ͼ40 mg/ml) was, however, weaker than that of 1. Resistoflavin methyl ether (3b) showed MIC values of 3.1 mg/ml against Bacillus subtilis (1: 6.2 m g/ml). Activity against Escherichia coli, Streptococcus aureus, and Candida albicans using the agar diffusion method was found at 10 mg/ml. Resistomycin (1) and resistoflavin methyl ether (3b) showed also antioxidative properties using the DPPH method [16] .
Experimental

Materials and Methods
IR spectra were recorded on a Perkin-Elmer 1600 Series FT-IR spectrometer as KBr pellets. UV-VIS-spectrum were recorded on Perkin-Elmer Lamda 15 UV/VIS spectrometer. NMR spectra were measured on Varian VXR 200, VXR 300, VXR 500 (tetramethylsilane as internal standard). Mass spectra were recorded on a Finnigan MAT 95 instrument (70 eV, high resolution with perfluorokerosene as reference). Rf values were measured on Polygram SIL G/UV254 (Macherey-Nagel & Co.). Column chromatography: Silica gel 60 (0.05ϳ0.2 mm and 0.04ϳ0.063 mm/230ϳ400 mesh, Macherey-Nagel & CO). Assay discs: i.d. 9 mm, Schleicher & Schuell, Dassel, Germany. Size exclusion chromatography was done on Sephadex LH-20 (Pharmacia). High speed counter current chromatography was done on a HSCCC Chromatograph (P. C. Inc., model HSCCC).
Fermentation of Streptomyces sp. B8005
Agar cultures of Streptomyces sp. isolate B8005 incubated for 72 hours at 28°C were used for the inoculation of ninety 1 litre Erlenmeyer flasks each containing 165 ml of maltextract yeast -extract medium [8] . After an incubation of 4 days at 28°C on a horizontal shaker at 110 rpm, the culture broth was mixed with Celite and filtered through a press filter to separate the mycelium from the water phase. Both phases were separately extracted with ethyl acetate. Due to the similarity shown on TLC, both organic phases were combined and evaporated to dryness. The crude extract was dissolved in methanol (150 ml) and extracted with cyclohexane (150 ml) for defatting. The methanol phase (7.4 g of an orange red extract) was then separated by medium pressure column chromatography on silica gel with a chloroform/methanol-gradient (1 l CHCl 3 , 1 l CHCl 3 /1% MeOH, 1 l CHCl 3 /2% MeOH, 1 l CHCl 3 /5% MeOH, 1 l CHCl 3 /10% MeOH) into four fractions. After crystallisation from chloroform followed by purification of the solid by PTLC (CHCl 3 /12% MeOH), fraction I yielded resistoflavin (3a, 6 mg, R f ϭ0.72). Similarly, fraction III yielded 36 mg of resistomycin (1) as a yellow solid with R f ϭ0.66. From fraction IV, 7.5 mg of 1-hydroxy-1-norresistomycin (2, R f ϭ0.66) were obtained as an orange solid, which was further purified by PTLC (CHCl 3 /10% MeOH) followed by column chromatography on Sephadex LH-20 (CHCl 3 /10% MeOH). Fraction V was separated by HSCCC (ethyl acetate/cyclohexane/methanol/waterϭ3 : 2 : 2 : 3) with the upper phase as mobile phase. All red fractions were combined and purified by HPLC (MeCN/30% H 2 O→MeCN in 30 minutes) to get 5 mg of red tetracenomycin D (4, R f ϭ0.54).
Fermentation of Streptomyces sp. B4842
The fermentation of strain B 4842 was performed in a 20 litre jar fermentor containing 18 litres of malt extract medium [8] in synthetic sea water/tap water 1 : 1. The medium was adjusted to pH 7.8 and sterilised for 1 hour at 120°C, incubation was carried out at 28°C for 3 days with 533 automatic addition of 2 N NaOH to maintain the pH at 5ϳ6, and polypropylene glycol to control foaming. Sterile air was supplied (5 l/minute) and agitation was at 120 rpm. The entire culture broth was filtered over Celite, and the culture filtrate was extracted three times with each 5 litres of ethyl acetate. The combined organic layers were then evaporated to dryness to yield 1.6 g of crude extract. The latter was defatted with cyclohexane and the resulting polar residue was subjected to Sephadex LH-20 column chromatography with methanol. Antibiotically active fractions were chromatographed on silica gel (CHCl 3 /MeOH 70 : 30) to yield resistomycin (1, 44 mg) and the ether 3b (2.4 mg).
